GetTopicDetailResponse(id=455a8e3034, topicName=HER2突變, introduction=HER2突變, content=null, image=null, comments=1, allHits=1233, url=https://h5.medsci.cn/topic?id=8730, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=90804, tagList=[TagDto(tagId=90804, tagName=HER2突變)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2241485, encodeId=4fcc2241485ba, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=455a8e3034' target=_blank style='color:#2F92EE;'>#HER2突變#</a>, objectTitle=繪真約大咖 | 叢秀峰教授：肺癌患者需關(guān)注HER2突變、過表達(dá)/擴增，德曲妥珠單抗療效顯著, objectType=article, longId=854446, objectId=7e8c854446d4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230801/1690823491906_5579292.jpg, objectUrl=/article/show_article.do?id=7e8c854446d4, replyNumber=0, likeNumber=52, createdTime=2024-12-08, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=7e8c854446d4, moduleTitle=繪真約大咖 | 叢秀峰教授：肺癌患者需關(guān)注HER2突變、過表達(dá)/擴增，德曲妥珠單抗療效顯著, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7e8c854446d4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2200226, encodeId=ac522200226e6, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=455a8e3034' target=_blank style='color:#2F92EE;'>#HER2突變#</a>, objectTitle=罕見卻不少見！ HER2突變肺癌不容忽視！, objectType=article, longId=823060, objectId=8f178230608b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=8f178230608b, replyNumber=0, likeNumber=99, createdTime=2024-04-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=8f178230608b, moduleTitle=罕見卻不少見！ HER2突變肺癌不容忽視！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8f178230608b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2166594, encodeId=e600216659409, content=<a href='/topic/show?id=07fe10530819' target=_blank style='color:#2F92EE;'>#德曲妥珠單抗#</a>治療<a href='/topic/show?id=455a8e3034' target=_blank style='color:#2F92EE;'>#HER2突變#</a>的轉(zhuǎn)移<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細(xì)胞肺癌#</a>，ORR達(dá)50%，對腦轉(zhuǎn)移，疾病控制率高達(dá)92.9%！, objectTitle=J Clin Oncol：德曲妥珠單抗治療HER2突變的轉(zhuǎn)移非小細(xì)胞肺癌，ORR達(dá)50%，對腦轉(zhuǎn)移，疾病控制率高達(dá)92.9%！, objectType=article, longId=798799, objectId=5fd5e9879938, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20231023/f9512e894bf24df89b3685cec17bc35f.jpg, objectUrl=/article/show_article.do?id=5fd5e9879938, replyNumber=0, likeNumber=147, createdTime=2023-11-04, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亞, moduleDTOList=[ModuleDTO(moduleId=5fd5e9879938, moduleTitle=J Clin Oncol：德曲妥珠單抗治療HER2突變的轉(zhuǎn)移非小細(xì)胞肺癌，ORR達(dá)50%，對腦轉(zhuǎn)移，疾病控制率高達(dá)92.9%！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5fd5e9879938)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
